PD4-1-2: Incorporation of bevacizumab (B) and erlotinib...

PD4-1-2: Incorporation of bevacizumab (B) and erlotinib (Er) with induction (I) and concurrent (C) carboplatin (Cb)/paclitaxel (P) and 74 Gy of thoracic radiotherapy in stage III non-small cell lung cancer (NSCLS): preliminary report of a phase I/II trial

Socinski, Mark A., Morris, David E., Stinchcombe, Thomas E., Halle, Jan S., Moore, Dominic T., Tynan, Maureen T., Siegel, Monica A., Rosenman, Julian G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.jto.0000283372.25221.2b
Date:
August, 2007
File:
PDF, 178 KB
2007
Conversion to is in progress
Conversion to is failed